Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
0.9300
-0.0452 (-4.63%)
Nov 16, 2026, 9:45 AM EST - Market open
Decoy Therapeutics Revenue
Decoy Therapeutics had revenue of $307.43K in the quarter ending September 30, 2026. This brings the company's total for the last twelve months to $535.06K. That makes Decoy Therapeutics the 44,505th largest company in the world by revenue and 6,321st in the United States.
Revenue (ttm)
$535.06K
Revenue Growth
n/a
P/S Ratio
1.19
Revenue / Employee
$48,642
Employees
11
Market Cap
609.32K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 1.84M | -3.39M | -64.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Scinai Immunotherapeutics | 3.07M |
| GeoVax Labs | 852.28K |
| SciSparc | 679.00K |
| Endovia Health Sciences | 32.09K |
| Virax Biolabs Group | 12.42K |
| Valion Bio | -86.00K |
DCOY News
- 2 days ago - Decoy Therapeutics files $50M mixed securities shelf - TheFly
- 3 days ago - Decoy Therapeutics Registration statement: Registration filing - Filings
- 4 days ago - Decoy Therapeutics Quarterly report: Q3 2026 - Filings
- 4 days ago - Decoy Therapeutics Earnings release: Q3 2026 - Filings
- 6 days ago - Decoy Therapeutics Named “R&D Solution of the Year” in 2026 BioTech Breakthrough Awards - GlobeNewsWire
- 13 days ago - Decoy Therapeutics Provides Third Quarter 2026 Business Update - GlobeNewsWire
- 5 weeks ago - Decoy Therapeutics registers to sell 2.37M shares of common stock for holders - TheFly
- 5 weeks ago - Decoy Therapeutics Registration statement: Registration filing - Filings